John Reeder
Direktor/Vorstandsmitglied bei Drugs for Neglected Diseases initiative
Profil
John Reeder is currently the Director at Drugs for Neglected Diseases initiative.
Previously, he worked as the Director-Population Health Center at The Macfarlane Burnet Institute For Medical Research & Public.
He holds a doctorate degree from The University of Manchester.
Aktive Positionen von John Reeder
Unternehmen | Position | Beginn |
---|---|---|
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von John Reeder
Unternehmen | Position | Ende |
---|---|---|
The Macfarlane Burnet Institute For Medical Research & Public
The Macfarlane Burnet Institute For Medical Research & Public Miscellaneous Commercial ServicesCommercial Services The Macfarlane Burnet Institute For Medical Research & Public Health Ltd. provides medical research and public health services. Its programs include maternal health, disease elimination, behaviors and health risks, health security, and healthy ageing. The organization also focuses on women's and children's health; alcohol, other drugs and harm reduction; sexual and reproductive health; and young people's health. The organization was founded in 1986 headquartered in Melbourne, Australia. | Corporate Officer/Principal | - |
Ausbildung von John Reeder
The University of Manchester | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Health Technology |
The Macfarlane Burnet Institute For Medical Research & Public
The Macfarlane Burnet Institute For Medical Research & Public Miscellaneous Commercial ServicesCommercial Services The Macfarlane Burnet Institute For Medical Research & Public Health Ltd. provides medical research and public health services. Its programs include maternal health, disease elimination, behaviors and health risks, health security, and healthy ageing. The organization also focuses on women's and children's health; alcohol, other drugs and harm reduction; sexual and reproductive health; and young people's health. The organization was founded in 1986 headquartered in Melbourne, Australia. | Commercial Services |